12^th International Conference on Cardiology and Cardiovascular Medicine Research June 03-04, 2023 Berlin, Germany

On the behalf of conference series academics, young researchers doctors, medical students, cardiologist and delegates which one that is that the battlefront of this barrier in covid 19 time

With the huge and ebullient presence of adepts, young and brilliant researchers, Professors, Doctors, and outstanding student communities, Interventional cardiology, failure and Cardiovascular Disease gives an insight into the foremost recent research and leading edge technology, which attracts enormous curiosity.

The purpose of the Interventional Cardiology, cardiopathy and Cardiovascular Disease meeting is to assemble a multidisciplinary group of Scientists and Researchers, Professors, and Doctors from round the world to present and exchange cutting-edge ideas associated with the Cardiology.

Meeting promotes top-level research and to globalize the standard research normally, making discussions and presentations more competitive internationally and focusing attention on the recent outgrowths.

We looking ahead the outstanding meeting of all the dignitaries from different-different national or international country and this program are slated on 03-04 June in Berlin Germany

Conference Agenda includes:

Why to attend?

MOLECULAR CARDIOLOGY 2023 with people from around the world focused on getting some answers concerning Cardiology, this is your single most obvious opportunity to accomplish the greatest accumulation of individuals from the mending focuses, Universities, bunch, etc. This Molecular Cardiology 2023 will coordinate appears, disperse information, and meet with recurring pattern and potential investigators and get name affirmation at this 2-day event. Broadly acclaimed speakers, the most recent frameworks, methodologies, and the most current updates in Cardiology field are indications of this conference. This World Cardiology Congress or rather all cardiology gatherings, cardiology events and cardiologists congress will help in frameworks organization, B2B uniting amidst specialists and academicians.

• 1.Sports Cardiology
• 2.Cardiac Devices
• 3.Cardiac Magnetic resonance imaging scan
• 4.Cardiac Regeneration
• 5.Cardio Diabetes
• 6.Cardio immunology
• 7.Cardio-oncology
• 8.Cardiovascular Surgery
• 9.Case reports on Cardiology
• 10.Clinical Cardiology
• 11.Covid 19 effect on Heart
• 12.Diet and Exercises
• 13.Digital Cardiology
• 14.Geriatric cardiology
• 15.Heart Disease in Females
• 16.Heart disease in pregnant women
• 17.Heart Diseases and Heart Failure
• 18.Heart Rhythm and Arrhythmias
• 19.Inherited Cardiac Disease
• 20.Molecular Cardiology
• 21.Multimodality Imaging
• 22.Neuroradiology
• 23.Nuclear cardiology
• 24.Obesity and Cardiac Diseases
• 25.Paediatric Cardiology
• 26.Stem Cell and cardiology

Growth of Cardiology Market:

The global cardiac biomarker diagnostic test kits market is expected to be worth US$ 2,540.8 MN in 2028, and is projected to increase at a CAGR of 5.1% through 2028. North America is expected to be a dominant market, which accounted for US$ 522.5 MN in 2017, and is expected to grow at a CAGR of 4.3%.

North America has been the dominant regional market for heart diagnostics with a share of approximately 47% of the overall heart diagnostics market in terms of revenue in 2022, followed by Europe which accounted for around 38% share in the market and then by Asia accounting for 15% share.

Governments are trying to limit hospital readmissions to reduce the prevalence of hospital acquired infections (HAIs) by imposing penalties on hospitals. As a result, adoption of home healthcare, remote patient monitoring, and long term care services is rapidly increasing. Thus, demand for cardiovascular devices is increasing from hospitals, patients based in home settings, and long term care centers. In addition, favorable government policies such as reimbursement coverage are fueling adoption of these devices. Thus, increasing target patient population, rising acceptance of home healthcare, and favorable government policies are some of the major factors driving the growth of the global cardiovascular devices market.

On the other hand, high device cost and stringent regulatory approval procedure are some of the prime factors challenging the growth of the market. In addition, lack of skilled professionals to perform surgical procedures using advanced devices is impeding the adoption of new devices. The global cardiac monitoring market is expected to register a CAGR of around 4%. North America accounted for the highest market value in 2022. However, Middle East & Africa is expected to register the highest CAGR during the forecast period. Cardiovascular diseases have become one of the primary reasons for mortality and are becoming a major concern in most parts of the world. Coronary heart disease (CHD) is the most common type of heart disease, with a death toll of more than 370,000 people annually. The American Heart Association (AHA) reports cardiovascular disease to be the leading global cause of death, accounting for 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030. The Heart Foundation also states that CVD is a major cause of death in Australia, with 45,053 deaths attributed to CVD in the country, in 2022.

Global Cardiovascular Information System Market Size and Forecast:

The Global Cardiovascular Data system Market was valued at USD 665.27 million in 2016 and is projected to flourish in USD 1,269.09 million by 2025, growing at a CAGR of 7 .4% from 2017 to 2025.

The increasing pervasiveness of cardiovascular diseases (CVDs) is predicted to spice up the enlargement of the worldwide cardiovascular Information system Market over the forecast period. The increasing prevalence of cardiovascular diseases like cardiac failure, arrhythmias, and ischemic heart situation is that the chief driver of the worldwide Cardiovascular Information system Market. The increasing number of challenges related to cardiovascular care including the organization of huge amounts of knowledge, data retrieval, and therefore the maintenance of patient history records is forming the inevitability for progressive systems, like Electronic Health Record (EHR) systems, which might facilitate data 

Industries Associated with Cardiology Research:

• Medtronic, Inc.

• Boston Scientific Corporation

• St. Jude Medical, Inc.

• Abbott Laboratories

• Cordis Corporation

• BIOTRONIK SE & Co. KG

• Sorin S. P. A.

• Edwards Life sciences Corporation

• Terumo Corporation

• Biosense Webster, Inc.

• C. R. Bard, Inc.

• AGA Medical Holdings, Inc.

• MAQUET GmbH & Co. KG

• Sahajanand Medical Technologies Pvt. Ltd.

• Vascular Concepts Limited

• GE Healthcare

• Philips Healthcare

• Fukuda Denshi Co., Ltd.

• Cardiac Science Corporation

• Welch Allyn Inc.

• ZOLL Medical Corporation

• Eurocor GmbH

• B. Braun Melsungen AG

• OSI Systems, Inc.

• W. L. Gore & Associates, Inc.

• Berlin Heart GmbH

• Thoratec Corporation

• Nihon Kohden Corporation

• Teleflex Incorporated

Universities Associated with Cardiology Research:

World Wide:

• Harvard University

• Cornell University

• Yale University

• University of Texas South-western medical center

• University of Michigan

• University of Washington

• Harvard University

• Vanderbilt University

• University of Rochester

• University of Alabama-Birmingham

• Emory University

• Northwestern University

• Vanderbilt University

Pharmaceutical Companies in France

•  Novartis       

• Sanofi Mylan Servier

• Pfizer

• Merck & Co

• Johnson & Johnson

• Roche

• Bristol-Myers Squibb

• Bayer

• Astrazeneca

• Celgene

• Novo Nordisk

• Fresenius

• Aurobindo

List of hospitals in France:

• Hôpital Necker

• Hôpital Saint-Louis

• Hôpital Hôtel-Dieu

• Hôpital Américain de Paris

• Hôpital Européen Georges Pompidou

• Hôpital Pitié Salpêtrière

• Hôpital Saint Joseph

• Hôpital des Diaconesses

• Hôpital Cochin

• Hôpital Lariboisiere

Importance and Scope:

Cardiology is a branch of medicine treatment with disorders of the heart. It includes analysis and treatment of CAD, coronary failure, Electrophysiology, Inherited heart illness and Congenital Heart Faults. Cardiologists study the dysfunctions of the heart, but the study of adolescent and child heart disorders are through divergent training pathways. The surgical piece aren't included in cardiology and are within the discipline of cardiothoracic surgery, for example, Cardiopulmonary bypass and Coronary artery bypass surgery are two surgical procedures performed by Cardiac surgeons, not cardiologists.